State Street’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.52M Sell
780,145
-8,876
-1% -$40K ﹤0.01% 3087
2025
Q1
$3.5M Sell
789,021
-525,388
-40% -$2.33M ﹤0.01% 3025
2024
Q4
$10.3M Buy
1,314,409
+104,628
+9% +$819K ﹤0.01% 2620
2024
Q3
$15.9M Buy
1,209,781
+405,169
+50% +$5.33M ﹤0.01% 2345
2024
Q2
$9.72M Buy
804,612
+53,539
+7% +$647K ﹤0.01% 2576
2024
Q1
$12.2M Sell
751,073
-10,459
-1% -$170K ﹤0.01% 2457
2023
Q4
$5.19M Buy
761,532
+20,434
+3% +$139K ﹤0.01% 2928
2023
Q3
$4.04M Sell
741,098
-3,509
-0.5% -$19.1K ﹤0.01% 3027
2023
Q2
$5.06M Sell
744,607
-18,223
-2% -$124K ﹤0.01% 2992
2023
Q1
$3.82M Sell
762,830
-69,321
-8% -$347K ﹤0.01% 3092
2022
Q4
$4.06M Sell
832,151
-1,086,988
-57% -$5.3M ﹤0.01% 3124
2022
Q3
$27.7M Buy
1,919,139
+175,997
+10% +$2.54M ﹤0.01% 1994
2022
Q2
$26.4M Sell
1,743,142
-565,640
-24% -$8.56M ﹤0.01% 2053
2022
Q1
$27.4M Buy
2,308,782
+852,112
+58% +$10.1M ﹤0.01% 2168
2021
Q4
$23.6M Buy
1,456,670
+124,727
+9% +$2.02M ﹤0.01% 2352
2021
Q3
$38M Sell
1,331,943
-57,568
-4% -$1.64M ﹤0.01% 2009
2021
Q2
$47M Sell
1,389,511
-319,910
-19% -$10.8M ﹤0.01% 1891
2021
Q1
$51.7M Buy
1,709,421
+766,418
+81% +$23.2M ﹤0.01% 1727
2020
Q4
$46.7M Sell
943,003
-106,933
-10% -$5.29M ﹤0.01% 1682
2020
Q3
$40.3M Buy
1,049,936
+94,347
+10% +$3.62M ﹤0.01% 1608
2020
Q2
$41.3M Buy
955,589
+167,194
+21% +$7.22M ﹤0.01% 1572
2020
Q1
$20.6M Buy
788,395
+40,279
+5% +$1.05M ﹤0.01% 1821
2019
Q4
$23.4M Buy
748,116
+394,181
+111% +$12.3M ﹤0.01% 2035
2019
Q3
$9.22M Buy
353,935
+31,878
+10% +$831K ﹤0.01% 2510
2019
Q2
$7.37M Buy
322,057
+239,895
+292% +$5.49M ﹤0.01% 2632
2019
Q1
$2.15M Buy
82,162
+16,765
+26% +$439K ﹤0.01% 3124
2018
Q4
$1.33M Buy
+65,397
New +$1.33M ﹤0.01% 3260